diclofenac has been researched along with Adenocarcinoma Of Kidney in 2 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thai, KJ | 1 |
| Ralph, C | 1 |
| England, D | 1 |
| Yanaihara, H | 1 |
| Nakazono, M | 1 |
| Tsunoda, S | 1 |
2 other studies available for diclofenac and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Treatment of Cabozantinib-Related Palmar-Plantar Erythrodysesthesia With Topical Sildenafil, Diclofenac, and Gabapentin Cream: A Case Report.
Topics: Administration, Cutaneous; Aged; Anilides; Carcinoma, Renal Cell; Diclofenac; Gabapentin; Hand-Foot | 2020 |
[A case of drug-induced immune hemolytic anemia during alpha-interferon therapy for renal cell carcinoma].
Topics: Anemia, Hemolytic, Autoimmune; Carcinoma, Renal Cell; Diclofenac; Female; Humans; Indomethacin; Inte | 1996 |